FINWIRES · TerminalLIVE
FINWIRES

IperionX Titanium Fasteners Meet or Exceed SAE Grade 8 Steel in US Army-Backed Testing

By

IperionX (ASX:IPX) said independent testing by the US Army Combat Capabilities

Development Command Ground Vehicle Systems Center and Westmoreland Mechanical Testing & Research found its Ti-6Al-4V fasteners can meet or exceed SAE Grade 8 steel performance in torque-to-failure, torque-tension, and tensile strength tests, according to a Monday Australian bourse filing.

Army testing showed that larger fasteners exceeded the yield torque of comparable Grade 8 steel, while smaller fasteners performed at or above steel levels, with some not yielding at the initial test thresholds, per the filing.

Independent tensile testing measured yield strengths of 135 to 137 kilopounds per square inch (ksi) and ultimate tensile strengths of 149 to 152 ksi, meeting or exceeding key aerospace and high-strength steel standards, the filing said.

The results highlight scalable, lower-cost titanium fasteners for defense and industrial use, reinforcing the company's role in developing a domestic US titanium supply chain via its powder-to-product technology, the filing added.

The company's shares were up over 1% in recent Monday trade.

Related Articles

Asia

Rural Funds Group Declares Quarterly Dividend

Rural Funds Group (ASX:RFF) declared a dividend of AU$0.029325 per share for the quarter ending June 30, according to a Monday Australian bourse filing.The dividend will be paid on July 31 to shareholders on record as of June 30.The company paid the same dividend for the prior corresponding period, an earlier filing showed.

$ASX:RFF
Asia

Atturra Appoints New CFO

Atturra (ASX:ATA) appointed Kunal Shah as its Chief Financial Officer, effective July 6, according to a Monday Australian bourse filing.Outgoing CFO Herb To will continue to support an orderly transition and will remain with the firm until Sept. 1.Shah previously served as CFO before Atturra's listing in 2021.

$ASX:ATA
Asia

4DMedical to Acquire Austrian Medical AI Company Contextflow in Cash, Stock Deal; Shares Up 6%

4DMedical (ASX:4DX) signed a binding agreement to acquire Austria-based contextflow, a medical technology company specializing in lung cancer screening and advanced artificial intelligence-driven thoracic imaging, in a deal that includes upfront cash payments of about AU$18.6 million, according to a Monday Australian bourse filing.The deal also includes 56,235 ordinary shares, plus an earn-out of up to 2.6 million zero-exercise-price options over two years subject to performance milestonesThe company said the acquisition establishes an immediate European commercial and clinical platform, with contextflow retaining about AU$30.8 million in accumulated tax losses.The acquisition introduces insurance reimbursement contracts in Germany and helps expand the company's CT:VQ product across the region, per the filing.4DMedical's shares jumped nearly 6% in recent Monday trade.

$ASX:4DX